August 22, 2025

Dendrimer-Based SN38 Nanoparticle Shows Favorable Safety and Activity in Advanced Solid Tumors

In an early-phase study reported in the Journal of Clinical Oncology, Liu et al evaluated the efficacy and safety of DEP-SN38, a polylysine-based dendrimer-nanoparticle conjugate of SN38, the active m...

The ASCO Post

August 22, 2025

Age Threshold for Survival Benefit of Adding Oxaliplatin to Adjuvant Chemotherapy in Stage II and III Colorectal Cancer

In a Korean retrospective study reported in JAMA Network Open, Bong et al found that the addition of oxaliplatin to fluoropyrimidine-based adjuvant chemotherapy was associated with a survival benefit ...

The ASCO Post

August 22, 2025

Two ACS Studies Show Colorectal Cancer Screening and Early Diagnosis Have Soared in Adults Aged 45 to 49 Years

A pair of studies by the American Cancer Society show that increases in colorectal cancer screening in adults aged 45 to 49 years are resulting in rises in earlier-stage diagnosis—12% per year from 20...

The ASCO Post

August 18, 2025

Plenary Highlights Across Tumor Types Reflect Advances in Research, Improvements in Care, and Changes in Practice

The 2025 ASCO Annual Meeting included the presentation of data from more than 7,000 abstracts and clinical trials set to advance research, uncover findings, and in some cases change the standard of pr...

The ASCO Post

August 11, 2025

Conquering rectal cancer with personalized care

After a cancer diagnosis, Sarah Murad is now cancer-free thanks to expert, minimally invasive care.

UCI Health

January 02, 2025

FDA Approves Nivolumab and Hyaluronidase-nvhy for Subcutaneous Injection

On December 27, 2024, the U.S. Food and Drug Administration approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for subcutaneous injection across approved adult, solid tumor nivolumab indicatio...

The ASCO Post

August 02, 2023

Gastrointestinal Symptoms May Be Prevalent in Geriatric Female Colorectal Cancer Survivors

About 80% of geriatric female colorectal cancer survivors may experience a range of gastrointestinal symptoms years after receiving a diagnosis and treatment for their tumors, according to a recent st...

The ASCO Post

December 04, 2023

Consuming Navy Beans May Improve Gut Health, Regulate Immune and Inflammatory Processes in Colorectal Cancer Survivors

Researchers investigated whether the regular consumption of navy beans could help improve the gut microbiome of colorectal cancer survivors.

The ASCO Post

November 13, 2023

FDA Approves Fruquintinib for Refractory Metastatic Colorectal Cancer

On November 8, the FDA approved an anti-VEGF tyrosine kinase inhibitor for adult patients with metastatic colorectal cancer who received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based che...

The ASCO Post